News

September 29, 2010 - Preclinical data of a therapy designed to treat drug-resistant hypertension was presented last week at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium in Washington, D.C.

Home September 29, 2010
Home
News

September 29, 2010 – Physicians from the Cedars-Sinai Heart Institute will lead a clinical trial evaluating transcatheter aortic valve implantation (TAVI) for patients who experience severe aortic stenosis and who may be at an elevated risk for open-heart surgery. The trial will study St. Jude Medical’s transcatheter aortic valve.

Home September 29, 2010
Home
News

September 29, 2010 – Results from a trial studying the effects of a drug-eluting balloon (DEB) on peripheral artery disease (PAD) were released at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium.

Home September 29, 2010
Home
Feature | Dave Fornell

Transcatheter valve therapies were among the hottest topics at the 2010 Transcatheter Cardiovascular Therapeutics (TCT) symposium and the key presentation was the very positive first release of data from the U.S. PARTNER trial. The trial results are widely expected to open the door to a major transition away from surgical to transcatheter aortic valve repair in the coming years.

Home September 29, 2010
Home
News

September 29, 2010 – A prospective study found that an implantable cardiac monitor detected arrhythmias in patients who had suffered a heart attack.

Home September 29, 2010
Home
Technology

September 29, 2010 – An agreement was reached between AccessClosure and Benrikal Services for distributing vascular closure devices in the United States. AccessClosure will be the exclusive distributor for the Bengal Radial Compression Band, which helps close the radial artery after a cardiovascular procedure.

Home September 29, 2010
Home
News

September 28, 2010 – The Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium featured a live case broadcast of a physician implanting a new device to treat refractory angina.

Home September 28, 2010
Home
News

September 28, 2010 – A new multinational trial will examine the effectiveness of embolic protection mesh stents in STEMI (ST-elelvated myocardial infarction) patients. The MASTER trial will compare the MGuard coronary stent, made by InspireMD, with standard care. The MGuard stent is covered in a polymer mesh to prevent emboli from escaping when the stent is expanded.

Home September 28, 2010
Home
Technology

September 28, 2010 – A guiding catheter specifically designed for right radial access to maximize transradial interventional procedures is released in the United States. Terumo Interventional System’s Heartrail III Coronary Guiding Catheter is designed for use in the left or right coronary artery.

Home September 28, 2010
Home
News

September 28, 2010 - Software downloaded during a routine office visit cuts the risk of inappropriate shocks by 50 percent for patients with implantable cardioverter defibrillators (ICD), according to research reported in Circulation: Journal of the American Heart Association.

Home September 28, 2010
Home
News

September 28, 2010 – Three-year follow-up data from the HORIZONS-AMI trial presented at Transcatheter Cardiovascular Therapeutics (TCT) 2010 last week continues to show marked improvement of paclitaxel-eluting stents over bare metal stents in acute myocardial infarction (AMI).

Home September 28, 2010
Home
News

September 28, 2010 – A fully automatic, all-in-one ultrasound cleansing and disinfection system, the Mides Transesophageal (TEE)-Care, offers ease-of-use and safe handling. It was recently introduced in Europe.

Home September 28, 2010
Home
Technology

September 28, 2010 – Physicians can now determine whether a patient needs to have cardiac radionuclide imaging (RNI) by using a new smartphone app. The app, which is available for free on iPhone, BlackBerry and Android phones, gives physicians access to published criteria used to assess the need for RNI.

Home September 28, 2010
Home
News

September 27, 2010 – A post-market study investigating a new treatment for peripheral artery disease of the superficial femoral artery (SFA) has completed enrollment. The VIPER study, which is looking at the performance of the Gore Viabahn endoprosthesis with a heparin bioactive surface, enrolled 120 patients.

Home September 27, 2010
Home
Technology

September 27, 2010 — A new plug-in quickly and easily assesses clinically relevant parameters for abdominal aortic aneurysm (AAA) stent planning.

Home September 27, 2010
Home
Subscribe Now